Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2008-02-25

FDA Approved: RESTORIL — Supplemental Application (SpecGx LLC)

View source ↗

Summary

The FDA approved a supplemental application for RESTORIL (temazepam) filed by SpecGx LLC. The action updates the product labeling under the supplemental approva…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RESTORIL (temazepam)

Snippet

SUPPL AP for RESTORIL (TEMAZEPAM)